Evidence map›Paper›PMID 27436264›Full record

ArticleEuropean journal of human genetics : EJHG2016

Copy number variations in 375 patients with oesophageal atresia and/or tracheoesophageal fistula.

Erwin Brosens, Florian Marsch, Elisabeth M de Jong, Hitisha P Zaveri, Alina C Hilger, Vera Gisela Choinitzki, Alice Hölscher, Per Hoffmann, Stefan Herms, Thomas M Boemers and 17 more

Open access · bronzeAbstract read
In one paragraph

Article in European journal of human genetics : EJHG, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
3.5field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors at 5 institutions in 4 countries.

Erwin BrosensDepartment of Clinical Genetics, Erasmus Medical Centre - Sophia Children's Hospital, Rotterdam, The Netherlands.ORCID 0000-0001-8235-4010
Florian MarschInstitute of Human Genetics, University of Bonn, Bonn, Germany.
Elisabeth M de JongDepartment of Clinical Genetics, Erasmus Medical Centre - Sophia Children's Hospital, Rotterdam, The Netherlands.
Hitisha P ZaveriDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA.
Alina C HilgerInstitute of Human Genetics, University of Bonn, Bonn, Germany.
Vera Gisela ChoinitzkiInstitute of Human Genetics, University of Bonn, Bonn, Germany.
Alice HölscherDepartment of Paediatric Surgery and Urology, Children's Hospital of Cologne, Cologne, Germany.
Per HoffmannInstitute of Human Genetics, University of Bonn, Bonn, Germany.ORCID 0000-0002-6573-983X
Stefan HermsInstitute of Human Genetics, University of Bonn, Bonn, Germany.
Thomas M BoemersDepartment of Paediatric Surgery and Urology, Children's Hospital of Cologne, Cologne, Germany.
Benno M UreCenter of Paediatric Surgery Hannover, Hannover Medical School and Bult Children's Hospital, Hannover, Germany.
Martin LacherCenter of Paediatric Surgery Hannover, Hannover Medical School and Bult Children's Hospital, Hannover, Germany.
Michael LudwigDepartment of Clinical Chemistry and Clinical Pharmacology, University of Bonn, Bonn, Germany.
Bert H EussenDepartment of Clinical Genetics, Erasmus Medical Centre - Sophia Children's Hospital, Rotterdam, The Netherlands.
Robert M van der HelmDepartment of Clinical Genetics, Erasmus Medical Centre - Sophia Children's Hospital, Rotterdam, The Netherlands.
Hannie DoubenDepartment of Clinical Genetics, Erasmus Medical Centre - Sophia Children's Hospital, Rotterdam, The Netherlands.
Diane Van OpstalDepartment of Clinical Genetics, Erasmus Medical Centre - Sophia Children's Hospital, Rotterdam, The Netherlands.
Rene M H WijnenDepartment of Paediatric Surgery, Erasmus Medical Centre - Sophia Children's Hospital, Rotterdam, The Netherlands.
H Berna BeverlooDepartment of Clinical Genetics, Erasmus Medical Centre - Sophia Children's Hospital, Rotterdam, The Netherlands.
Yolande van BeverDepartment of Clinical Genetics, Erasmus Medical Centre - Sophia Children's Hospital, Rotterdam, The Netherlands.
Alice S BrooksDepartment of Clinical Genetics, Erasmus Medical Centre - Sophia Children's Hospital, Rotterdam, The Netherlands.
Hanneke IJsselstijnDepartment of Paediatric Surgery, Erasmus Medical Centre - Sophia Children's Hospital, Rotterdam, The Netherlands.
Daryl A ScottDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA.
Johannes SchumacherInstitute of Human Genetics, University of Bonn, Bonn, Germany.
Dick TibboelDepartment of Paediatric Surgery, Erasmus Medical Centre - Sophia Children's Hospital, Rotterdam, The Netherlands.
Heiko ReutterInstitute of Human Genetics, University of Bonn, Bonn, Germany.
Annelies de KleinDepartment of Clinical Genetics, Erasmus Medical Centre - Sophia Children's Hospital, Rotterdam, The Netherlands.
Erasmus MC - Sophia Children’s Hospital · NLUniversity of Bonn · DEBaylor College of Medicine · USMedizinische Hochschule Hannover · DEUniversity Hospital Cologne · DE

Funding

Wellcome Trust
6 · The paper itself

Abstract

Oesophageal atresia (OA) with or without tracheoesophageal fistula (TOF) are rare anatomical congenital malformations whose cause is unknown in over 90% of patients. A genetic background is suggested, and among the reported genetic defects are copy number variations (CNVs). We hypothesized that CNVs contribute to OA/TOF development. Quantifying their prevalence could aid in genetic diagnosis and clinical care strategies. Therefore, we profiled 375 patients in a combined Dutch, American and German cohort via genomic microarray and compared the CNV profiles with their unaffected parents and published control cohorts. We identified 167 rare CNVs containing genes (frequency<0.0005 in our in-house cohort). Eight rare CNVs - in six patients - were de novo, including one CNV previously associated with oesophageal disease. (hg19 chr7:g.(143820444_143839360)_(159119486_159138663)del) 1.55% of isolated OA/TOF patients and 1.62% of patients with additional congenital anomalies had de novo CNVs. Furthermore, three (15q13.3, 16p13.3 and 22q11.2) susceptibility loci were identified based on their overlap with known OA/TOF-associated CNV syndromes and overlap with loci in published CNV association case-control studies in developmental delay. Our study suggests that CNVs contribute to OA/TOF development. In addition to the identified likely deleterious de novo CNVs, we detected 167 rare CNVs. Although not directly disease-causing, these CNVs might be of interest, as they can act as a modifier in a multiple hit model, or as the second hit in a recessive condition.

Indexed as

DNA Copy Number VariationsAdultChildEsophageal AtresiaGenetic LociGenome-Wide Association StudyHumansTracheoesophageal Fistula

Identifiers

PMID27436264
PMCPMC5117935
OpenAlexW2489012268

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.